Chengbin Ma

1.3k total citations
42 papers, 879 citations indexed

About

Chengbin Ma is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Chengbin Ma has authored 42 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Chengbin Ma's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (7 papers). Chengbin Ma is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (7 papers). Chengbin Ma collaborates with scholars based in China. Chengbin Ma's co-authors include Qiongwei Wu, Ping Liu, Zhiyu Zhang, Wenying Zhang, Haifei Zhang, Feng Wang, Fangyue Zhou, Guannan Zhou, Keqin Hua and Jingxin Ding and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Chengbin Ma

42 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengbin Ma China 18 407 312 156 142 122 42 879
Pei-Chin Chuang Taiwan 15 420 1.0× 191 0.6× 80 0.5× 52 0.4× 125 1.0× 24 728
Xingchen Li China 15 295 0.7× 185 0.6× 86 0.6× 153 1.1× 86 0.7× 76 851
Jingyu Liu China 13 583 1.4× 546 1.8× 79 0.5× 239 1.7× 88 0.7× 43 1.1k
Lianju Shen China 14 418 1.0× 147 0.5× 41 0.3× 151 1.1× 101 0.8× 31 722
Eun Ji Lee South Korea 13 257 0.6× 83 0.3× 112 0.7× 144 1.0× 41 0.3× 59 702
Andrey Elchaninov Russia 17 268 0.7× 81 0.3× 67 0.4× 272 1.9× 333 2.7× 94 1.1k
Jin Seok South Korea 13 267 0.7× 87 0.3× 76 0.5× 135 1.0× 95 0.8× 32 649
Se-Ra Park South Korea 14 197 0.5× 64 0.2× 98 0.6× 77 0.5× 146 1.2× 22 587
Baoshan Xu China 14 249 0.6× 52 0.2× 102 0.7× 128 0.9× 103 0.8× 47 651
Rossana Domenis Italy 19 687 1.7× 305 1.0× 21 0.1× 134 0.9× 179 1.5× 40 1.2k

Countries citing papers authored by Chengbin Ma

Since Specialization
Citations

This map shows the geographic impact of Chengbin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengbin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengbin Ma more than expected).

Fields of papers citing papers by Chengbin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengbin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengbin Ma. The network helps show where Chengbin Ma may publish in the future.

Co-authorship network of co-authors of Chengbin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Chengbin Ma. A scholar is included among the top collaborators of Chengbin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengbin Ma. Chengbin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Yuanyuan, Guannan Zhou, Fangyue Zhou, et al.. (2022). Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health. Frontiers in Endocrinology. 13. 808508–808508. 64 indexed citations
2.
Gu, Yuanyuan, Guannan Zhou, Fangyue Zhou, et al.. (2022). Life Modifications and PCOS: Old Story But New Tales. Frontiers in Endocrinology. 13. 808898–808898. 53 indexed citations
3.
Cui, Kai, et al.. (2020). PLK1 Knockdown Inhibits Cell Proliferation and Cell Apoptosis, and PLK1 Is Negatively Regulated by miR-4779 in Osteosarcoma Cells. DNA and Cell Biology. 39(5). 747–755. 9 indexed citations
4.
Jiang, Wenhao, Yanan Liu, Wanfeng Huang, et al.. (2020). Blocking STAT3 by pyrvinium pamoate causes metabolic lethality in KRAS-mutant lung cancer. Biochemical Pharmacology. 177. 113960–113960. 18 indexed citations
5.
Zhao, Duoyi, et al.. (2019). Primary Ewing's sarcoma of the vertebral body. Medicine. 98(24). e15905–e15905. 3 indexed citations
6.
Li, Tao, et al.. (2019). Clinical efficacy of carvedilol treatment for dilated cardiomyopathy. Medicine. 98(18). e15403–e15403. 3 indexed citations
7.
Ma, Chengbin, Wenying Zhang, Qiongwei Wu, et al.. (2018). Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma. PLoS ONE. 13(3). e0193625–e0193625. 10 indexed citations
8.
Zhang, Wenying, et al.. (2018). AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells. Molecular and Cellular Biochemistry. 448(1-2). 311–320. 50 indexed citations
9.
Liu, Ping, et al.. (2016). MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3. Cancer Cell International. 16(1). 67–67. 24 indexed citations
10.
Ma, Chengbin, et al.. (2016). Silencing FAT10 inhibits metastasis of osteosarcoma. International Journal of Oncology. 49(2). 666–674. 14 indexed citations
11.
Ma, Chengbin, et al.. (2016). MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma. Oncology Reports. 35(6). 3257–3264. 23 indexed citations
12.
Cui, Yan, et al.. (2015). Interleukin 10 gene −1082A/G polymorphism is associated with osteosarcoma risk and poor outcomes in the Chinese population. Tumor Biology. 37(4). 4517–4522. 8 indexed citations
13.
Zhang, Zhiyu, Feng Wang, Qin Li, et al.. (2015). CD151 knockdown inhibits osteosarcoma metastasis through the GSK-3β/β-catenin/MMP9 pathway. Oncology Reports. 35(3). 1764–1770. 24 indexed citations
14.
Ma, Chengbin, et al.. (2015). Molecular mechanisms underlying endometriosis pathogenesis revealed by bioinformatics analysis of microarray data. Archives of Gynecology and Obstetrics. 293(4). 797–804. 35 indexed citations
15.
Wang, Feng, et al.. (2015). Comparison of bipolar hemiarthroplasty and total hip arthroplasty for displaced femoral neck fractures in the healthy elderly: a meta-analysis. BMC Musculoskeletal Disorders. 16(1). 229–229. 96 indexed citations
16.
Liu, Ping, et al.. (2014). Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1. Tumor Biology. 35(12). 11933–11938. 79 indexed citations
17.
Liu, Ping, Meiyan Qi, Chengbin Ma, et al.. (2013). Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora‐B. FEBS Letters. 587(16). 2523–2529. 33 indexed citations
18.
Ma, Chengbin, Yan Liu, Wenying Zhang, & Ping Liu. (2013). The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18, 628 individuals. Molecular Biology Reports. 40(3). 2061–2068. 8 indexed citations
19.
Zhang, Wenying, et al.. (2012). Clearance of high‐risk HPV infection in Chinese women with normal cervical cytology. International Journal of Gynecology & Obstetrics. 118(1). 74–75. 1 indexed citations
20.
Zhang, Dan, et al.. (2012). Data Mining of Spatial-Temporal Expression of Genes in the Human Endometrium During the Window of Implantation. Reproductive Sciences. 19(10). 1085–1098. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026